Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00379340 · OUTCOME

Event Free Survival Associated With the Burden of Pulmonary Metastatic Disease

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor · Source last updated 2026-07-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Probability
Interval / dispersion
95% Confidence Interval
Time frame
At 4 years

What was measured

Probability of no relapse, secondary malignancy, or death after 4 year in the study.

Analysis population: Analysis population is eligible stage (stg) IV patients (pts) with lung mets only. On Participant Flow table, these pts include 120 RCR, 135 SIR, 21 stg IV with LOH (of 52 when including stg III), and 23 stg IV with lung mets (off therapy before week 6). A total of 299 stg IV pts, exceeding the total number of participant (297) analyzed for OM 4.

Groups in this outcome

Lung Mets <= 1cm

Lung mets \<= 1cm

Lung Mets > 1cm

Lung mets \> 1cm

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Lung Mets <= 1cm147
Lung Mets > 1cm150

Reported measurements

Source class 1
Values in Probability · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Lung Mets <= 1cm0.88Not reported0.820.95Not reported
Lung Mets > 1cm0.82Not reported0.750.90Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0.82
        upper Limit
        0.95
        value
        0.88
      2. group Id
        OG001
        lower Limit
        0.75
        upper Limit
        0.90
        value
        0.82
denoms
  1. counts
    1. group Id
      OG000
      value
      147
    2. group Id
      OG001
      value
      150
    units
    Participants
description
Probability of no relapse, secondary malignancy, or death after 4 year in the study.
dispersion Type
95% Confidence Interval
groups
  1. description
    Lung mets \<= 1cm
    id
    OG000
    title
    Lung Mets <= 1cm
  2. description
    Lung mets \> 1cm
    id
    OG001
    title
    Lung Mets > 1cm
param Type
NUMBER
population Description
Analysis population is eligible stage (stg) IV patients (pts) with lung mets only. On Participant Flow table, these pts include 120 RCR, 135 SIR, 21 stg IV with LOH (of 52 when including stg III), and 23 stg IV with lung mets (off therapy before week 6). A total of 299 stg IV pts, exceeding the total number of participant (297) analyzed for OM 4.
reporting Status
POSTED
time Frame
At 4 years
title
Event Free Survival Associated With the Burden of Pulmonary Metastatic Disease
type
SECONDARY
unit Of Measure
Probability

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice